π Which statin should you choose?
All statins block HMG-CoA reductase β the liver makes less cholesterol β more LDL receptors β more LDL cleared. LDL βββ Β· HDL β Β· TG β β and they lower mortality in CAD.
The choice comes down to the patient π
π« ATORVASTATIN β after MI / ACS
Moderate or high intensity, easy to titrate. Minimal renal excretion, so it's usable in CKD.
π§ ROSUVASTATIN β the most potent
Also a post-MI choice. Few drug interactions, long half-life. Hydrophilic, so it's often better tolerated after muscle symptoms (not guaranteed) β start low, at 5 mg.
π PRAVASTATIN β many medications
Very few drug interactions and often tolerated after muscle symptoms. Lower potency: no high-intensity dose.
ποΈ PITAVASTATIN β HIV
In the REPRIEVE trial it cut major cardiovascular events by about 35% in adults with HIV. Always check the antiretroviral regimen.
β οΈ SIMVASTATIN β interactions
Older, with outcome data, but many interactions: amiodarone and some calcium-channel blockers need dose limits.
π§ Exam point: muscle pain on a statin? Think myopathy β the risk rises with fibrates or niacin. Also watch for β LFTs.
π Save this for your next pharmacology review.
Synthesa β Learn better. Care better.
#Synthesa #statins #pharmacology #cardiologyeducation #USMLE #MedEd
